Registro:

Referencias:

• Bell, D.S., Stroke in the diabetic patient (1994) Diabetes Care, 17, pp. 213-219
• Knopman, D., Boland, L.L., Mosley, T., Howard, G., Liao, D., Szklo, M., Cardiovascular risk factors and cognitive decline in middle-aged adults (2001) Neurology, 56, pp. 42-44
• Peila, R., Rodríguez, B.L., Launer, L.J., Type 2 diabetes. APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study (2002) Diabetes, 51, pp. 1256-1262
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus (1993) N Engl J Med, 329, pp. 977-986. , The Diabetes Control and Complications Trial Research Group
• Alexander, C.M., Landsman, P.B., Teutsch, S.M., Haffner, S.M., NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older (2003) Diabetes, 52, pp. 1210-1214
• Miyakawa, T., Vascular pathology in Alzheimer's disease (2010) Psychogeriatrics, 10, pp. 39-44
• Tuppo, E.E., Arias, H.R., The role of inflammation in Alzheimer's disease (2005) Int J Biochem Cell Biol, 37, pp. 289-305
• Luchsinger, J.A., Diabetes, related conditions, and dementia (2010) J Neurol Sci, 299, pp. 35-38
• Kapogiannis, D., Mattson, M.P., Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease (2011) Lancet Neurol, 10, pp. 187-198
• Fernández-Gamba, A., Leal, M.C., Morelli, L., Castaño, E.M., Insulin-degrading enzyme: Structure-function relationship and its possible roles in health and disease (2009) Curr Pharm Des, 15, pp. 3644-3655
• Honig, L.S., Tang, M.X., Albert, S., Costa, R., Luchsinger, J., Manly, J., Stroke and the risk of Alzheimer disease (2003) Arch Neurol, 60, pp. 1707-1712
• Hachinski, V.C., Potter, P., Merskey, H., Leuko-araiosis (1987) Arch Neurol, 44, pp. 21-23
• Domínguez, R.O., Famulari, A.L., Gallo, A., García, G., Bartolomé, E., D'Abbraccio, G., Early onset of leuko-araiosis in hypertensive patients (1993) Arch Neurol, 50, pp. 13-14
• Reijmer, Y.D., van den Berg, E., Ruis, C., Jaap Kappelle, L., Biessels, G.J., Cognitive dysfunction in patients with type 2 diabetes (2010) Diabetes Metab Res Rev, 27, pp. 195-202
• Verdelho, A., Madureira, S., Moleiro, C., Ferro, J.M., Santos, C.O., Erkinjuntti, T., White matter changes and diabetes predict cognitive decline in the elderly: The LADIS study (2010) Neurology, 75, pp. 160-167
• Brands, A.M., Biessels, G.J., Kappelle, L.J., de Haan, E.H., de Valk, H.W., Algra, A., Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: A comparative study (2007) Dement Geriatr Cogn Disord, 23, pp. 343-350
• Tiehuis, A.M., Vincken, K.L., van den Berg, E., Hendrikse, J., Manschot, S.M., Mali, W.P., Cerebral perfusion in relation to cognitive function and type 2 diabetes (2008) Diabetologia, 51, pp. 1321-1326
• Hoyer, S., Glucose metabolism and insulin receptor signal transduction in Alzheimer disease (2004) Eur J Pharmacol, 490, pp. 115-125
• Rivera, E.J., Goldin, A., Fulmer, N., Tavares, R., Wands, J.R., de la Monte, S.M., Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine (2005) J Alzheimers Dis, 8, pp. 247-268
• Janson, J., Laedtke, T., Parisi, J.E., O'Brien, P., Petersen, R.C., Butler, P.C., Increased risk of type 2 diabetes in Alzheimer disease (2004) Diabetes, 53, pp. 474-481
• Kubota, T., Kubota, N., Moroi, M., Terauchi, Y., Kobayashi, T., Kamata, K., Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury (2003) Circulation, 107, pp. 3073-3080
• Dick, P.J., Karnes, J.L., O'Brien, P., Okazaki, H., Lais, A., Engelstad, J., The spatial distribution of fiber loss in diabetic polineuropathy suggests ischemia (1986) Ann Neurol, 19, pp. 440-449
• Brownlee, M., Cerami, A., Vlassara, H., Advanced glycosilation end products in tissue and the biochemical basis of diabetic complications (1988) N Engl J Med, 318, pp. 1315-1321
• Low, P.A., Nickander, K.K., Oxygen free radical effects in sciatic nerve in experimental diabetes (1991) Diabetes, 40, pp. 873-877
• Pagano, M.A., Basile, R.M., Krinsky, F., Dacordi, H., Yorio, A., Sánchez, G.G., Compromiso del tronco cerebral en la Diabetes Mellitus (1988) Rev Soc Arg Diabetes, 22, p. 53
• Asvold, B.O., Sand, T., Hestad, K., Bjorgaas, M.R., Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycemia: A 16-year follow-up study (2010) Diabetes Care, 33, pp. 1945-1947
• Lovestone, S., Reynolds, C.H., The phosphorylation of tau (τ): A critical stage in neurodevelopmental and neurodegenerative processes (1997) Neuroscience, 78, pp. 309-324
• Sonnen, J.A., Larson, E.B., Brickell, K., Crane, P.K., Woltjer, R., Craft, S., Different patterns of cerebral injury in dementia with or without diabetes (2009) Arch Neurol, 66, pp. 315-322
• Ba-Tin, L., Strike, P., Tabet, N., Diabetic peripheral microvascular complications: Relationship to cognitive function (2011) Cardiovasc Psychiatry Neurol, p. 723434
• Serra, J.A., Marschoff, E.R., Domínguez, R.O., Guareschi, E.M., Famulari, A.L., Pagano, M.A., Oxidative stress in Alzheimer's and vascular dementias: Masking of the antioxidant profiles by a concomitant type ii diabetes mellitus condition (2004) J Neurol Sci, 218, pp. 17-24
• Domínguez, R.O., Marschoff, E.R., Guareschi, E.M., Famulari, A.L., Pagano, M.A., Serra, J.A., Homocysteine, vitamin B12 and folate in Alzheimer's and vascular dementias: The paradoxical effect of the superimposed type ii diabetes mellitus condition (2005) Clin Chim Acta, 359, pp. 163-170
• Cankurtaran, M., Yesil, Y., Kuyumcu, M.E., Oztürk, Z.A., Yavuz, B.B., Halil, M., Altered levels of homocysteine and serum natural antioxidants links oxidative damage to Alzheimer's disease (2013) J Alzheimers Dis, 33, pp. 1051-1058
• Domínguez, R.O., Marschoff, E.R., Guareschi, E.M., Repetto, M.G., Famulari, A.L., Pagano, M.A., Serra, J.A., Insulin, glucose and glycated hemoglobin in Alzheimer's and vascular dementia with and without superimposed Type II diabetes mellitus condition (2008) J Neural Transm., 115, pp. 77-84
• De Felice, F.G., Vieira, M.N.N., Bomfim, T.R., Decker, H., Velasco, P.T., Lambert, M.P., Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of A-β oligomers (2009) Proc Natl Acad Sci USA., 106, pp. 1971-1976
• Serra, J.A., Domínguez, R.O., Marschoff, E.R., Guareschi, E.M., Famulari, A.L., Boveris, A., Systemic oxidative stress associated with the neurological diseases of aging (2009) Neurochem Res., 34, pp. 2122-2132
• Kickstein, E., Krauss, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J., Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling (2010) Proc Natl Acad Sci USA., 107, pp. 21830-21835
• Gupta, A., Bisht, B., Dey, C.S., Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes (2011) Neuropharmacology, 60, pp. 910-920
• Li, J., Deng, J., Sheng, W., Zuo, Z., Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice (2012) Pharmacol Biochem Behav., 10, pp. 564-574
• Craft, S., Baker, L.D., Montine, T.J., Minoshima, S., Watson, G.S., Claxton, A., Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial (2012) Arch Neurol., 69, pp. 29-38
• Ramasamy, R., Vannucci, S.J., Yan, S.S., Herold, K., Yan, S.F., Schmidt, A.M., Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation (2005) Glycobiology, 15, pp. 16R-28R
• Yan, S., Chen, X., Schmidt, A., Brett, J., Godman, G., Scott, C., Glycated tau in Alzheimer's disease: A mechanism for induction of oxidative stress (1994) Proc Natl Acad Sci USA., 91, pp. 7787-7791
• Munch, G., Schinzel, R., Loske, C., Wong, A., Duray, N., Riederer, P., Alzheimer's disease synergistics effects of glucose deficit, oxidative stress and advanced glycation endproducts (1998) J Neural Transm., 105, pp. 439-461
• Rolo, A., Palmeira, C., Diabetes and mitocondrial function: role of hyperglycemia and oxidative stress (2006) Toxicol Appl Pharmacol., 212, pp. 167-178
• de Lustig, E.S., Serra, J.A., Kohan, S., Canziani, G., Famulari, A.L., Domínguez, R.O., Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging (1993) J Neurol Sci., 115, pp. 18-25
• Serra, J.A., Domínguez, R.O., de Lustig, E.S., Guareschi, E.M., Famulari, A.L., Bartolomé, E.L., Parkinson's disease is associated with oxidative stress: Comparison of peripheral antioxidant profiles in living Parkinson's (2001) Alzheimer's and vascular dementia patients. J Neural Transm., 108, pp. 1135-1148
• Sies, H., Oxidative stress: from basic research to clinical application (1991) Am J Med., 91, pp. 31-38S
• Hanbali, A., Al-Khasawneh, K., Cole-Johnson, C., Divine, G., Ali, H., Protective effect of diabetes against metastasis in patients with non-small cell lung cancer (2007) Arch Intern Med, 167, p. 513
• Waters, K.M., Henderson, B.E., Stram, D.O., Wan, P., Kolonel, L.N., Haiman, C.A., Association of diabetes with prostate cancer risk in the multiethnic cohort (2009) Am J Epidemiol, 169, pp. 937-945
• Sanz, C., Andrieu, S., Sinclair, A., Hanaire, H., Vellas, B., Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease (2009) Neurology, 73, pp. 1359-1366. , Real fr Study Group
• Baraka, A., ElGhotny, S., Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats (2010) Eur J Pharmacol, 64, pp. 123-127
• Domínguez, R.O., Marschoff, E.R., González, S.E., Repetto, M.G., Serra, J.A., Type 2 Diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients (2012) Diabetes Res Clin Pract., 98, pp. 68-74

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------